FDA Approves Endologix Stent Grafts As First “Totally Percutaneous” AAA Repair Systems
This article was originally published in The Gray Sheet
Endologix plans to begin training physicians to deliver its percutaneous AAA endovascular repair systems later this year following FDA approval of the new indication.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.